1. Liodakis E, Antoniou J, Zukor DJ, Huk OL, Epure LM, Bergeron SG. Major complications and transfusion rates after hemiarthroplasty and total hip arthroplasty for femoral neck fractures. J Arthroplasty. 2016; 31(9):2008–2012. PMID:
26975602.
Article
2. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology. 2010; 113(2):482–495. PMID:
20613475.
3. Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty: correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br. 2004; 86(4):561–565. PMID:
15174554.
4. Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic surgery transfusion hemoglobin European overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003; 43(4):459–469. PMID:
12662278.
Article
5. Ponnusamy KE, Kim TJ, Khanuja HS. Perioperative blood transfusions in orthopaedic surgery. J Bone Joint Surg Am. 2014; 96(21):1836–1844. PMID:
25378512.
Article
6. Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty. 2013; 28(8 Suppl):34–37. PMID:
23896359.
Article
7. Saleh A, Small T, Chandran Pillai AL, Schiltz NK, Klika AK, Barsoum WK. Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009. J Bone Joint Surg Am. 2014; 96(18):e155. PMID:
25232085.
Article
8. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 2003; 54(5):908–914. PMID:
12777903.
Article
9. Carson JL, Duff A, Berlin JA, et al. Perioperative blood transfusion and postoperative mortality. JAMA. 1998; 279(3):199–205. PMID:
9438739.
Article
10. Kotze A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth. 2012; 108(6):943–952. PMID:
22593128.
11. Shander A, Van Aken H, Colomina MJ, et al. Patient blood management in Europe. Br J Anaesth. 2012; 109(1):55–68. PMID:
22628393.
Article
12. van Iperen CE, Kraaijenhagen RJ, Biesma DH, Beguin Y, Marx JJ, van de Wiel A. Iron metabolism and erythropoiesis after surgery. Br J Surg. 1998; 85(1):41–45. PMID:
9462381.
Article
13. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005; 352(10):1011–1023. PMID:
15758012.
Article
14. Mundy GM, Birtwistle SJ, Power RA. The effect of iron supplementation on the level of haemoglobin after lower limb arthroplasty. J Bone Joint Surg Br. 2005; 87(2):213–217. PMID:
15736746.
Article
15. Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet. 2008; 101(1):67–73. PMID:
18234203.
Article
16. Bisbe E, Molto L, Arroyo R, Muniesa JM, Tejero M. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. Br J Anaesth. 2014; 113(3):402–409. PMID:
24780615.
Article
17. Suh YS, Nho JH, Choi HS, Ha YC, Park JS, Koo KH. A protocol avoiding allogeneic transfusion in joint arthroplasties. Arch Orthop Trauma Surg. 2016; 136(9):1213–1226. PMID:
27450193.
Article
18. Song JH, Park JW, Lee YK, et al. Management of blood loss in hip arthroplasty: Korean Hip Society current consensus. Hip Pelvis. 2017; 29(2):81–90. PMID:
28611958.
Article
19. Khalafallah A, Al-Barzan AM, Chan J, et al. A prospective randomized controlled trial to assess the effect of intravenous versus oral iron therapy in the treatment of preoperative anaemia. J Blood Disord Transfus. 2012; 3(4):127.
Article
20. Beris P, Munoz M, Garcia-Erce JA, Thomas D, Maniatis A, Van der. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth. 2008; 100(5):599–604. PMID:
18372258.
Article
21. Fishbane S. Review of issues relating to iron and infection. Am J Kidney Dis. 1999; 34(4 Suppl 2):S47–S52. PMID:
10516376.
Article
22. Zager RA, Johnson AC, Hanson SY, Wasse H. Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. Am J Kidney Dis. 2002; 40(1):90–103. PMID:
12087566.
Article
23. Walters BA, Van Wyck DB. Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients. Nephrol Dial Transplant. 2005; 20(7):1438–1442. PMID:
15840683.
Article
24. Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015; 90(1):12–23. PMID:
25572192.
25. Munoz M, Naveira E, Seara J, Cordero J. Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. Br J Anaesth. 2012; 108(3):532–534. PMID:
22337966.
26. Munoz M, Gomez-Ramirez S, Cuenca J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion. 2014; 54(2):289–299. PMID:
23581484.
Article
27. Khalafallah AA, Yan C, Al-Badri R, et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. Lancet Haematol. 2016; 3(9):e415–e425. PMID:
27570088.
Article
28. Rohrig G, Steinmetz T, Stein J, et al. Efficacy and tolerability of ferric carboxymaltose in geriatric patients with anemia: data from three non-interventional studies. MMW Fortschr Med. 2014; 156(Suppl 2):48–53.